Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: dual agent chemoimmunotherapy ×

dual agent chemoimmunotherapy

This treatment is selected. Its supporting articles are shown below.

dual agent chemoimmunotherapy1

Articles mentioning dual agent chemoimmunotherapy

1 articles · page 1 of 1

1152 Comparing outcomes with single versus dual agent chemoimmunotherapy for patients with PD-L1 negative metastatic non-small cell lung cancer (NSCLC)

jitc · abstract · 2025-11-04 · 1 matching annotations

80.7%

single agent chemoimmunotherapy dual agent chemoimmunotherapy immunotherapy pembrolizumab NSCLC nivolumab KEYNOTE-189 KEYNOTE-407 non-small cell lung cancer ipilimumab

…nt chemoimmunotherapy (with anti-PD-1/PD-L1 and anti-CTLA4) and single agent chemoimmunotherapy (with anti-PD-1/PD-L1); however, direct comparisons of these re…

Browse treatments

dual agent chemoimmunotherapy

Articles mentioning dual agent chemoimmunotherapy

1152 Comparing outcomes with single versus dual agent chemoimmunotherapy for patients with PD-L1 negative metastatic non-small cell lung cancer (NSCLC)